Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News InVivo Therapeutics Holdings Corp NVIVQ

Healthcare Medical Devices
InVivo Therapeutics Holdings Corp. is a research and clinical-stage biomaterials and biotechnology company with a focus on the treatment of spinal cord injuries (SCIs). The Company's Neuro-Spinal Scaffold implant is an investigational bioresorbable polymer scaffold that is designed for implantation at the site of injury within a spinal cord. It is intended to promote appositional, or side-by... see more

Recent & Breaking News (OTCPK:NVIVQ)

InVivo Therapeutics Appoints Lou Vaickus, MD as Interim Chief Medical Officer

Business Wire October 11, 2013

InVivo Therapeutics to Present at 2013 Aegis Healthcare Conference

Business Wire September 23, 2013

InVivo Therapeutics Appoints Gregory D. Perry as Interim CFO

Business Wire September 17, 2013

InVivo Therapeutics Announces Personnel Changes

Business Wire September 9, 2013

InVivo Therapeutics to Present at 15th Annual Rodman and Renshaw Healthcare Conference

Business Wire September 5, 2013

NVIV, AAMRQ, FNMA and EKDKQ added to OTC Active Stock Watch List at EPR

Accesswire September 4, 2013

GSAT, AFFY, AAMRQ and NVIV added to OTC Active Stock Watch List at EPR

Accesswire August 27, 2013

InVivo Therapeutics Updates Clinical Plan

Business Wire August 27, 2013

InVivo Therapeutics Announces Change in Leadership

Business Wire August 22, 2013

InVivo Therapeutics and the New York Mets Present Spinal Cord Injury Awareness Day

Business Wire July 10, 2013

InvestorsGuru.com 32 Filtered Mid-Day Market Movers Recap

Investors Guru June 30, 2013

InVivo Therapeutics CEO's Appearance on Fox News Channel's "Tech Take" to be Available on FoxNews.com

Business Wire June 27, 2013

InVivo Therapeutics' CEO to Appear on Fox News Channel's "Tech Take"

Business Wire June 26, 2013

The Real Story Behind LOTE, DPHS, POLR and NVIV

Marketwired June 5, 2013

InVivo Therapeutics' Frank Reynolds Named a "CFO of the Year" Finalist by Boston Business Journal

Business Wire June 5, 2013

InVivo Therapeutics Raises $16.1 Million from Warrant Call and Exercises Paving Way for Up-Listing to a National Securities Exchange

Business Wire June 4, 2013

Interview with InVivo Therapeutics' CEO to be Aired on Boston's NPR Station WBUR This Morning

Business Wire May 21, 2013

InVivo Therapeutics Announces Webcast for Annual Shareholders Meeting to Be Held on May 23rd

Business Wire May 17, 2013

InVivo Therapeutics Sponsors 8th Annual Working 2 Walk Spinal Cord Injury Symposium

Business Wire May 16, 2013

InVivo Therapeutics Reports First Quarter 2013 Financial Results, Provides Business Update

Business Wire May 9, 2013